Christian Pagnoux
Christian Pagnoux is an expert in Rheumatology at Mount Sinai Hospital (Canada) (Canada). As of October 2026, ScienceLeadR ranks Christian Pagnoux in the top 1% of experts worldwide for Vasculitis, Arteritis and Autoimmune Diseases. Christian Pagnoux has authored 537 publications, the most recent in 2026, and is an investigator in 24 clinical trials, 2 of them ongoing. SLR score: 1,663 (community average: 125). How the SLR is computed.
LeadR Profile
Rheumatology
Subspecialties: Immunology - Internal Medicine - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1995 - 2026
Number : 537
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Utility of follow-up cardiac magnetic resonance imaging in patients with eosinophilic granulomatosis with polyangiitis. PMID 42873715 — rheumatology, magnetic resonance imaging, connective tissue diseases, diagnosis, granulomatosis with polyangiitis | Clin Exp Rheumatol | 2026 | 0 |
| Drug-associated central nervous system vasculitis and reversible cerebral vasoconstriction syndrome: A global disproportionality analysis of the WHO pharmacovigilance database (VigiBase). PMID 42706935 — vasculitis, vasoconstriction, pharmaceutical preparations, thyroid gland, central nervous system, pharmacology, sex, vasculitis, central nervous system, nervous system, pharmacovigilance | Br J Clin Pharmacol | 2026 | 0 |
| French guidelines for the diagnosis and management of primary central nervous system vasculitis. PMID 42562678 — vasculitis, internal medicine, adrenal cortex hormones, biopsy, immunosuppressive agents, maintenance, central nervous system, diagnosis, therapeutics, vasculitis, central nervous system, nervous system | Rev Med Interne | 2026 | 0 |
| Biosimilar Rituximab in ANCA-Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study. PMID 42532981 — vasculitis, cohort studies, maintenance, rituximab, anti-neutrophil cytoplasmic antibody-associated vasculitis, therapeutics, biosimilar pharmaceuticals | ACR Open Rheumatol | 2026 | 0 |
| Chronic Rhinosinusitis and Nasal Polyps in Eosinophilic Granulomatosis With Polyangiitis: A Scoping Review. PMID 42439219 — vasculitis, hypersensitivity, polyps, prevalence, diagnosis, therapeutics, nasal polyps, sinusitis, granulomatosis with polyangiitis, rhinosinusitis | Int Forum Allergy Rhinol | 2026 | 0 |
Clinical Studies 24
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 13
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Optic Nerve Sheath Ultrasound in Giant Cell Arteritis NCT05749094 — cells, research design, peripheral nervous system diseases, blood, axillary artery, eyelids, ophthalmology, optic neuropathy, ischemic, peripheral nervous system, arteries, optic nerve, arteritis, signs and symptoms, giant cells, nervous system, polymyalgia rheumatica, nervous system diseases, hematologic tests, optic nerve diseases, giant cell arteritis, ischemia | N/A | Recruiting | 2025 |
| Abatacept for the Treatment of Giant Cell Arteritis NCT04474847 — injections, cells, glucocorticoids, vasculitis, anti-inflammatory agents, prednisone, antirheumatic agents, adrenal cortex hormones, immunosuppressive agents, arteritis, solutions, immune system diseases, abatacept, giant cells, immune system, autoimmune diseases, therapeutics, therapeutic uses, injections, subcutaneous, giant cell arteritis, pharmacologic actions | Phase 3 | Recruiting | 2021 |
LeadR Networks
Main global connection map